Medicenna in the spotlight (part VI)

Executive management shifts and future outlook

Last week, Medicenna (MDNA) announced a clinical advisory board and strategic advisors. In the end of the press release, MDNA disclosed that Chief Scientific Officer Dr. Kevin Moulder left his position to pursue another opportunity. In the last two months, both the Chief Scientific Officer and Chief Medical Officer have left Medicenna. This is not a goo…